Will Pfizer ETFs Gain on Positive COVID-19 Booster Dose Data?

Pfizer Inc. PFE and BioNTech SE BNTX recently announced encouraging data from a Phase 3 randomized, controlled trial studying the efficiency and safety levels of a 30-µg booster dose of their COVID-19 vaccine. The trial included more than 10,000 ...

from Google Alert - Business https://ift.tt/3GmATRr
Pfizer Inc. PFE and BioNTech SE BNTX recently announced encouraging data from a Phase 3 randomized, controlled trial studying the efficiency and safety levels of a 30-µg booster dose of their COVID-19 vaccine. The trial included more than 10,000 ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize